Treatment for plexiform neurofibromas in patients with NF1.

The Lancet. Oncology ·Vol. 13 ·No. 12 ·2012-12-00 ·页码 1175-6

Ardern-Holmes SL, North KN

Abstract

暂无摘要

MeSH 主题词

Antineoplastic Agents/therapeutic use Benzamides Female Humans Imatinib Mesylate Male Neurofibroma, Plexiform/drug therapy Neurofibromatosis 1/complications Piperazines/therapeutic use Protein Kinase Inhibitors/therapeutic use Pyrimidines/therapeutic use

化学物质

Antineoplastic Agents Benzamides Piperazines Protein Kinase Inhibitors Pyrimidines Imatinib Mesylate

作者与单位

共 2 位作者，点击展开单位 / ORCID

Ardern-Holmes Simone L

TY Nelson Department of Neurology and Neurosurgery, Sydney Medical School, University of Sydney, NSW, Australia. simone.ardernholmes@health.nsw.gov.au

North Kathryn N

Article Info

Journal

The Lancet. Oncology

Abbr.

Lancet Oncol

ISSN

1474-5488

DOI

10.1016/S1470-2045(12)70435-7

Corresponding email

simone.ardernholmes@health.nsw.gov.au

Published

2012-12-00

电子出版

2012-00-23

页码

1175-6

Language

English

Country/Region

England

NLM ID

100957246

勘误 / 撤稿关联

CommentOn

PMID: 23099009

External Links

PubMed source DOI: 10.1016/S1470-2045(12)70435-7 View journal details

Analysis Services

Treatment for plexiform neurofibromas in patients with NF1.

Contact

WeChat Official Account